Literature DB >> 14572927

Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives.

Sandra D Taylor1.   

Abstract

Predictive testing is one of the new genetic technologies which, in conjunction with developing fields such as pharmacogenomics, promises many benefits for preventive and population health. Understanding how individuals appraise and make genetic test decisions is increasingly relevant as the technology expands. "Lay" understandings of genetic risk and test decision-making, located within holistic life frameworks including family or kin relationships, may vary considerably from clinical representations of these phenomena. The predictive test for Huntington's disease (HD), whilst specific to a single-gene, serious, mature-onset but currently untreatable disorder, is regarded as a model in this context. This paper reports upon a qualitative Australian study which investigated predictive test decision-making by individuals at risk for HD, the contexts of their decisions and the appraisals which underpinned them. In-depth interviews were conducted in Australia with 16 individuals at 50% risk for HD, with variation across testing decisions, gender, age and selected characteristics. Findings suggested predictive testing was regarded as a significant life decision with important implications for self and others, while the right "not to know" genetic status was staunchly and unanimously defended. Multiple contexts of reference were identified within which test decisions were located, including intra- and inter-personal frameworks, family history and experience of HD, and temporality. Participants used two main criteria in appraising test options: perceived value of, or need for the test information, for self and/or significant others, and degree to which such information could be tolerated and managed, short and long-term, by self and/or others. Selected moral and ethical considerations involved in decision-making are examined, as well as the clinical and socio-political contexts in which predictive testing is located. The paper argues that psychosocial vulnerabilities generated by the availability of testing technologies and exacerbated by policy imperatives towards individual responsibility and self-governance should be addressed at broader societal levels.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2004        PMID: 14572927     DOI: 10.1016/s0277-9536(03)00155-2

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  23 in total

1.  Personal factors associated with reported benefits of Huntington disease family history or genetic testing.

Authors:  Janet K Williams; Cheryl Erwin; Andrew Juhl; James Mills; Bradley Brossman; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2010-08-19

2.  Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Authors:  Yvonne Bombard; JoAnne Palin; Jan M Friedman; Gerry Veenstra; Susan Creighton; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-10       Impact factor: 3.568

3.  Nationwide survey on predictive genetic testing for late-onset, incurable neurological diseases in Japan.

Authors:  Kunihiro Yoshida; Takahito Wada; Akihiro Sakurai; Keiko Wakui; Shu-Ichi Ikeda; Yoshimitsu Fukushima
Journal:  J Hum Genet       Date:  2007-07-05       Impact factor: 3.172

Review 4.  Information processing in the context of genetic risk: implications for genetic-risk communication.

Authors:  Holly Etchegary; Colin Perrier
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.537

5.  Decision-making about inherited cancer risk: exploring dimensions of genetic responsibility.

Authors:  Holly Etchegary; Fiona Miller; Sonya deLaat; Brenda Wilson; June Carroll; Mario Cappelli
Journal:  J Genet Couns       Date:  2009-03-18       Impact factor: 2.537

6.  The Ethics of General Population Preventive Genomic Sequencing: Rights and Social Justice.

Authors:  Clair Morrissey; Rebecca L Walker
Journal:  J Med Philos       Date:  2018-01-12

7.  Experiences of teens living in the shadow of Huntington Disease.

Authors:  Kathleen J H Sparbel; Martha Driessnack; Janet K Williams; Debra L Schutte; Toni Tripp-Reimer; Meghan McGonigal-Kenney; Lori Jarmon; Jane S Paulsen
Journal:  J Genet Couns       Date:  2008-03-18       Impact factor: 2.537

8.  Decreasing uptake of predictive testing for Huntington's disease in a German centre: 12 years' experience (1993-2004).

Authors:  Christiane Bernhardt; Anne-Marie Schwan; Peter Kraus; Joerg Thomas Epplen; Erdmute Kunstmann
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

9.  "To perpetuate blindness!": attitudes of UK patients with inherited retinal disease towards genetic testing.

Authors:  Barbara Potrata; Martin McKibbin; Jennifer Nw Lim; Jenny Hewison
Journal:  J Community Genet       Date:  2013-12-24

10.  Diversity and uniformity in genetic responsibility: moral attitudes of patients, relatives and lay people in Germany and Israel.

Authors:  Aviad E Raz; Silke Schicktanz
Journal:  Med Health Care Philos       Date:  2009-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.